[go: up one dir, main page]

ES2192342T3 - 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa. - Google Patents

2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa.

Info

Publication number
ES2192342T3
ES2192342T3 ES98958016T ES98958016T ES2192342T3 ES 2192342 T3 ES2192342 T3 ES 2192342T3 ES 98958016 T ES98958016 T ES 98958016T ES 98958016 T ES98958016 T ES 98958016T ES 2192342 T3 ES2192342 T3 ES 2192342T3
Authority
ES
Spain
Prior art keywords
dioxo
isoindolinas
tnfalfa
fluoropiperidin
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98958016T
Other languages
English (en)
Inventor
George W Muller
David I Stirling
Roger Shen-Chu Chen
Hon-Wah Man
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/976,140 external-priority patent/US5874448A/en
Priority claimed from US09/042,274 external-priority patent/US5955476A/en
Application filed by Celgene Corp filed Critical Celgene Corp
Application granted granted Critical
Publication of ES2192342T3 publication Critical patent/ES2192342T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un compuesto seleccionado del grupo consistente de (a) 2-(2, 6-dioxo-3-fluoro-piperidin-3-il) isoindolina de la fórmula: **(Fórmula)** en que Y es oxígeno o H2 y cada uno de R1, R2, y R4, independientemente de los otros, es hidrógeno, halo, alquilo de 1 a 4 átomos de carbono, alcoxilo de 1 a 4 átomos de carbono, o amino y (b) las sales de adición ácida de dichos 2-(2, 6-dioxo-3fluoro-piperidin-3-il) isoindolinas que contienen un átomo de nitrógeno capaz de ser protonado.
ES98958016T 1997-11-18 1998-11-17 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa. Expired - Lifetime ES2192342T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/976,140 US5874448A (en) 1997-11-18 1997-11-18 Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
US09/042,274 US5955476A (en) 1997-11-18 1998-03-13 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels

Publications (1)

Publication Number Publication Date
ES2192342T3 true ES2192342T3 (es) 2003-10-01

Family

ID=26719049

Family Applications (2)

Application Number Title Priority Date Filing Date
ES98958016T Expired - Lifetime ES2192342T3 (es) 1997-11-18 1998-11-17 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa.
ES02028237T Expired - Lifetime ES2262753T3 (es) 1997-11-18 1998-11-17 2-(2.6-dioxo-3-fluorpiperidin-3-il)-isoindolinas substituidas y su empleo para reducir los niveles de tnfalfa.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02028237T Expired - Lifetime ES2262753T3 (es) 1997-11-18 1998-11-17 2-(2.6-dioxo-3-fluorpiperidin-3-il)-isoindolinas substituidas y su empleo para reducir los niveles de tnfalfa.

Country Status (14)

Country Link
EP (3) EP1710242A1 (es)
AT (2) ATE233753T1 (es)
AU (1) AU752958B2 (es)
CY (1) CY1106100T1 (es)
CZ (1) CZ299808B6 (es)
DE (2) DE69834668T2 (es)
DK (1) DK1308444T3 (es)
ES (2) ES2192342T3 (es)
FI (1) FI20001192A7 (es)
HK (1) HK1054381B (es)
NO (1) NO318737B1 (es)
PT (1) PT1308444E (es)
SI (1) SI1308444T1 (es)
SK (1) SK7382000A3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100712573B1 (ko) * 1998-03-16 2007-05-02 셀진 코포레이션 염증성 사이토카인 억제제용 2-(2,6-디옥소피페리딘-3-일)이소인돌린 유도체, 그 제조방법 및 그 용도
US20050100529A1 (en) * 2003-11-06 2005-05-12 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014455A1 (en) * 1991-02-14 1992-09-03 The Rockefeller University METHOD FOR CONTROLLING ABNORMAL CONCENTRATION TNF α IN HUMAN TISSUES
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE4422237A1 (de) * 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines
CZ302378B6 (cs) * 1996-07-24 2011-04-20 Celgene Corporation Optický izomer (S)-1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindolin a farmaceutická kompozice s jeho obsahem

Also Published As

Publication number Publication date
SK7382000A3 (en) 2000-12-11
ATE327228T1 (de) 2006-06-15
FI20001192L (fi) 2000-07-14
DE69834668D1 (de) 2006-06-29
CZ299808B6 (cs) 2008-12-03
AU1413899A (en) 1999-09-27
DE69811962T2 (de) 2003-08-28
EP1308444A1 (en) 2003-05-07
EP1062214A1 (en) 2000-12-27
HK1054381B (en) 2006-10-13
ATE233753T1 (de) 2003-03-15
NO20002529L (no) 2000-06-30
CZ20001822A3 (cs) 2000-11-15
HK1054381A1 (en) 2003-11-28
PT1308444E (pt) 2006-08-31
DK1308444T3 (da) 2006-09-18
NO20002529D0 (no) 2000-05-16
SI1308444T1 (sl) 2007-04-30
EP1062214B1 (en) 2003-03-05
AU752958B2 (en) 2002-10-03
DE69811962D1 (de) 2003-04-10
EP1308444B1 (en) 2006-05-24
DE69834668T2 (de) 2007-01-11
ES2262753T3 (es) 2006-12-01
NO318737B1 (no) 2005-05-02
CY1106100T1 (el) 2011-06-08
FI20001192A7 (fi) 2000-07-14
EP1710242A1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
AR240929A2 (es) "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas"
NO20013379L (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
CO5050332A1 (es) Composiciones fungicidas que comprenden 2-metoxibenzofenonas
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
EA200100428A1 (ru) Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты)
SE7906722L (sv) Merkaptoacylderivat av substituerade proliner
FR2662701B1 (fr) Composition tinctoriale a base de 5,6-dihydroxyindolines et procede de teinture des fibres keratiniques.
SE8704599L (sv) Teobrominderivat
DK0828742T3 (da) Diazepin-indoler som phoshodiesterase 4-inhibitorer
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
ES2064103T3 (es) Derivados de bifenil-guanidina sustituidos en posicion orto y agentes antidiabeticos o hipoglicemicos que los contienen.
EA200200810A1 (ru) Конденсированные соединения азола и их применение в качестве гипогликаемических агентов
UY24010A1 (es) Nuevos pirrolocarbazoles
TW427979B (en) A condensed piperidine compound
MY102744A (en) Aromatic derivatives, their preparation and thier use as antimicrobial agents.
FI892344A0 (fi) 6-fenyl-3-piperazinylalkyl-1h,3h -pyrimidin-2-4-dionderivat, deras framstaellning och deras terapeutiska anvaendning.
PL290676A1 (en) Method of obtaining novel derivatives of 2-aminoalkyl-5-diaryl-alkyl-1.3-dioxane
CO4520266A1 (es) Derivado de 1,3-oxazin-4-ona, el herbicida que lo contiene y los productos intermedios para prepararlo
PE20001241A1 (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
DK415789D0 (da) Tetracykliske antidepressive midler
MX170732B (es) Composicion de derivados de succinimida y su uso
ES2192342T3 (es) 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa.
NO910167L (no) Haarfargemiddel.
ES2081858T3 (es) Compuestos de beta-fenoxinitrilo.